Actinidia arguta Miq., commonly known as kiwiberry or hardy kiwifruit, is increasingly recognized as a multifunctional horticultural species with nutritional, phytochemical, and biotechnological value. Although research has traditionally focused on fruit quality, increasing evidence indicates that leaves, shoots, stems, roots, flowers, seeds, and processing residues contain diverse metabolites with potential applications in food, nutraceuticals, and biomass valorization. This review provides an integrated, organ-oriented analysis of the phytochemical composition, metabolic specialization, molecular regulation, biotechnological potential, and translational applications of A. arguta. Fruits are important sources of vitamin C, soluble sugars, organic acids, dietary fiber, actinidin, and polyphenols, whereas vegetative tissues accumulate phenolics, flavonoids, hydroxycinnamic acid derivatives, and pentacyclic triterpenoids. Seeds represent a lipid-rich compartment characterized by polyunsaturated fatty acids, particularly α-linolenic acid, as well as tocopherols and other lipophilic compounds. Floral tissues contribute diverse volatile metabolites, while processing residues provide additional sources of dietary fiber and bioactive compounds. Recent metabolomic, transcriptomic, and molecular studies reveal substantial effects of genotype, organ identity, developmental stage, and environmental conditions on phytochemical variation. Despite substantial progress, important gaps remain in multi-organ metabolomic characterization, standardization, bioavailability, safety assessment, and clinical validation. Overall, A. arguta can be considered a whole-plant resource with applications spanning functional foods, nutraceuticals, biotechnology, and sustainable biomass valorization.